Cargando…
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer
INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791854/ https://www.ncbi.nlm.nih.gov/pubmed/35118202 http://dx.doi.org/10.1016/j.ctro.2021.12.007 |
_version_ | 1784640275549782016 |
---|---|
author | Gerard, Jean-Pierre Montagne, Lucile Thamphya, Brice Doyen, Jerôme Schiappa, Renaud Benezery, Karene Gourgou, Sophie Dejean, Catherine Hannoun-Levi, Jean-Michel |
author_facet | Gerard, Jean-Pierre Montagne, Lucile Thamphya, Brice Doyen, Jerôme Schiappa, Renaud Benezery, Karene Gourgou, Sophie Dejean, Catherine Hannoun-Levi, Jean-Michel |
author_sort | Gerard, Jean-Pierre |
collection | PubMed |
description | INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. MATERIAL AND METHODS: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. RESULTS: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. CONCLUSION: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option. |
format | Online Article Text |
id | pubmed-8791854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87918542022-02-02 Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer Gerard, Jean-Pierre Montagne, Lucile Thamphya, Brice Doyen, Jerôme Schiappa, Renaud Benezery, Karene Gourgou, Sophie Dejean, Catherine Hannoun-Levi, Jean-Michel Clin Transl Radiat Oncol Article INTRODUCTION: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a “watch and wait” strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1-T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. MATERIAL AND METHODS: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. RESULTS: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. CONCLUSION: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option. Elsevier 2022-01-06 /pmc/articles/PMC8791854/ /pubmed/35118202 http://dx.doi.org/10.1016/j.ctro.2021.12.007 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Gerard, Jean-Pierre Montagne, Lucile Thamphya, Brice Doyen, Jerôme Schiappa, Renaud Benezery, Karene Gourgou, Sophie Dejean, Catherine Hannoun-Levi, Jean-Michel Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title | Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title_full | Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title_fullStr | Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title_full_unstemmed | Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title_short | Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer |
title_sort | propensity score analysis of radical proctectomy versus organ preservation using contact x-ray brachytherapy for rectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791854/ https://www.ncbi.nlm.nih.gov/pubmed/35118202 http://dx.doi.org/10.1016/j.ctro.2021.12.007 |
work_keys_str_mv | AT gerardjeanpierre propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT montagnelucile propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT thamphyabrice propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT doyenjerome propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT schiapparenaud propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT benezerykarene propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT gourgousophie propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT dejeancatherine propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer AT hannounlevijeanmichel propensityscoreanalysisofradicalproctectomyversusorganpreservationusingcontactxraybrachytherapyforrectalcancer |